Global Gallbladder Cancer Therapeutics Market 2024-2028

PUBLISHED: December 15, 2023

PAGES: 166 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The gallbladder cancer therapeutics market is forecasted to grow by USD 141.47 mn during 2023-2028, accelerating at a CAGR of 6.63% during the forecast period. The report on the gallbladder cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the strong incidence of gallbladder cancer in developing countries, risk factors of gallbladder cancer, and the advent of immunotherapy for the treatment of gallbladder cancer.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	5.42%
CAGR	6.63%
Incremental Value	$141.47mn

Technavio's gallbladder cancer therapeutics market is segmented as below:

By Type

Combination therapy
Monotherapy

By Application

Hospitals
Academic and medical centers
Others

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the strong pipeline for gallbladder cancer as one of the prime reasons driving the gallbladder cancer therapeutics market growth during the next few years. Also, the rising adoption of immunotherapy and next-generation sequencing (NGS) based testing will lead to sizable demand in the market.

The report on the gallbladder cancer therapeutics market covers the following areas:

Gallbladder cancer therapeutics market sizing
Gallbladder cancer therapeutics market forecast
Gallbladder cancer therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gallbladder cancer therapeutics market vendors that include AbbVie Inc., AstraZeneca Plc, B.Braun SE, Boston Scientific Corp., Bristol Myers Squibb Co., Conmed Corp., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Medtronic Plc, Merck KGaA, Novartis AG, Olympus Corp., Pfizer Inc., Sanofi SA, Smith and Nephew plc, and Sun Pharmaceutical Industries Ltd.. Also, the gallbladder cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR73560

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global gallbladder cancer therapeutics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global gallbladder cancer therapeutics market 2018 - 2022 ($ million)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Application Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Combination therapy - Market size and forecast 2023-2028
Exhibit 34: Chart on Combination therapy - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Combination therapy - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Combination therapy - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Combination therapy - Year-over-year growth 2023-2028 (%)
6.4 Monotherapy - Market size and forecast 2023-2028
Exhibit 38: Chart on Monotherapy - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Monotherapy - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Monotherapy - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Monotherapy - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Application

7.1 Market segments
Exhibit 44: Chart on Application - Market share 2023-2028 (%)
Exhibit 45: Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Exhibit 46: Chart on Comparison by Application
Exhibit 47: Data Table on Comparison by Application
7.3 Hospitals - Market size and forecast 2023-2028
Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
7.4 Academic and medical centers - Market size and forecast 2023-2028
Exhibit 52: Chart on Academic and medical centers - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Academic and medical centers - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Academic and medical centers - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Academic and medical centers - Year-over-year growth 2023-2028 (%)
7.5 Others - Market size and forecast 2023-2028
Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Application
Exhibit 60: Market opportunity by Application ($ million)
Exhibit 61: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share by geography 2023-2028 (%)
Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 India - Market size and forecast 2023-2028
Exhibit 99: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on India - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 103: Market opportunity by geography ($ million)
Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 111: AbbVie Inc. - Overview
Exhibit 112: AbbVie Inc. - Product / Service
Exhibit 113: AbbVie Inc. - Key news
Exhibit 114: AbbVie Inc. - Key offerings
12.4 B.Braun SE
Exhibit 115: B.Braun SE - Overview
Exhibit 116: B.Braun SE - Business segments
Exhibit 117: B.Braun SE - Key news
Exhibit 118: B.Braun SE - Key offerings
Exhibit 119: B.Braun SE - Segment focus
12.5 Boston Scientific Corp.
Exhibit 120: Boston Scientific Corp. - Overview
Exhibit 121: Boston Scientific Corp. - Business segments
Exhibit 122: Boston Scientific Corp. - Key news
Exhibit 123: Boston Scientific Corp. - Key offerings
Exhibit 124: Boston Scientific Corp. - Segment focus
12.6 Bristol Myers Squibb Co.
Exhibit 125: Bristol Myers Squibb Co. - Overview
Exhibit 126: Bristol Myers Squibb Co. - Product / Service
Exhibit 127: Bristol Myers Squibb Co. - Key news
Exhibit 128: Bristol Myers Squibb Co. - Key offerings
12.7 Conmed Corp.
Exhibit 129: Conmed Corp. - Overview
Exhibit 130: Conmed Corp. - Business segments
Exhibit 131: Conmed Corp. - Key offerings
Exhibit 132: Conmed Corp. - Segment focus
12.8 Eli Lilly and Co.
Exhibit 133: Eli Lilly and Co. - Overview
Exhibit 134: Eli Lilly and Co. - Product / Service
Exhibit 135: Eli Lilly and Co. - Key news
Exhibit 136: Eli Lilly and Co. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
Exhibit 137: F. Hoffmann La Roche Ltd. - Overview
Exhibit 138: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 139: F. Hoffmann La Roche Ltd. - Key news
Exhibit 140: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 141: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Gilead Sciences Inc.
Exhibit 142: Gilead Sciences Inc. - Overview
Exhibit 143: Gilead Sciences Inc. - Product / Service
Exhibit 144: Gilead Sciences Inc. - Key news
Exhibit 145: Gilead Sciences Inc. - Key offerings
12.11 Medtronic Plc
Exhibit 146: Medtronic Plc - Overview
Exhibit 147: Medtronic Plc - Business segments
Exhibit 148: Medtronic Plc - Key news
Exhibit 149: Medtronic Plc - Key offerings
Exhibit 150: Medtronic Plc - Segment focus
12.12 Novartis AG
Exhibit 151: Novartis AG - Overview
Exhibit 152: Novartis AG - Business segments
Exhibit 153: Novartis AG - Key offerings
Exhibit 154: Novartis AG - Segment focus
12.13 Olympus Corp.
Exhibit 155: Olympus Corp. - Overview
Exhibit 156: Olympus Corp. - Business segments
Exhibit 157: Olympus Corp. - Key news
Exhibit 158: Olympus Corp. - Key offerings
Exhibit 159: Olympus Corp. - Segment focus
12.14 Pfizer Inc.
Exhibit 160: Pfizer Inc. - Overview
Exhibit 161: Pfizer Inc. - Product / Service
Exhibit 162: Pfizer Inc. - Key news
Exhibit 163: Pfizer Inc. - Key offerings
12.15 Sanofi SA
Exhibit 164: Sanofi SA - Overview
Exhibit 165: Sanofi SA - Business segments
Exhibit 166: Sanofi SA - Key news
Exhibit 167: Sanofi SA - Key offerings
Exhibit 168: Sanofi SA - Segment focus
12.16 Smith and Nephew plc
Exhibit 169: Smith and Nephew plc - Overview
Exhibit 170: Smith and Nephew plc - Business segments
Exhibit 171: Smith and Nephew plc - Key news
Exhibit 172: Smith and Nephew plc - Key offerings
Exhibit 173: Smith and Nephew plc - Segment focus
12.17 Sun Pharmaceutical Industries Ltd.
Exhibit 174: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 175: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 176: Sun Pharmaceutical Industries Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations

Product Code: IRTNTR73560

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global gallbladder cancer therapeutics market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Combination therapy - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Combination therapy - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Combination therapy - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Combination therapy - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Monotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Monotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Monotherapy - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Monotherapy - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Application - Market share 2023-2028 (%)
Exhibits45: Data Table on Application - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Academic and medical centers - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Academic and medical centers - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Academic and medical centers - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Academic and medical centers - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Application ($ million)
Exhibits61: Data Table on Market opportunity by Application ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share by geography 2023-2028 (%)
Exhibits64: Data Table on Market share by geography 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity by geography ($ million)
Exhibits104: Data Tables on Market opportunity by geography ($ million)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AbbVie Inc. - Overview
Exhibits112: AbbVie Inc. - Product / Service
Exhibits113: AbbVie Inc. - Key news
Exhibits114: AbbVie Inc. - Key offerings
Exhibits115: B.Braun SE - Overview
Exhibits116: B.Braun SE - Business segments
Exhibits117: B.Braun SE - Key news
Exhibits118: B.Braun SE - Key offerings
Exhibits119: B.Braun SE - Segment focus
Exhibits120: Boston Scientific Corp. - Overview
Exhibits121: Boston Scientific Corp. - Business segments
Exhibits122: Boston Scientific Corp. - Key news
Exhibits123: Boston Scientific Corp. - Key offerings
Exhibits124: Boston Scientific Corp. - Segment focus
Exhibits125: Bristol Myers Squibb Co. - Overview
Exhibits126: Bristol Myers Squibb Co. - Product / Service
Exhibits127: Bristol Myers Squibb Co. - Key news
Exhibits128: Bristol Myers Squibb Co. - Key offerings
Exhibits129: Conmed Corp. - Overview
Exhibits130: Conmed Corp. - Business segments
Exhibits131: Conmed Corp. - Key offerings
Exhibits132: Conmed Corp. - Segment focus
Exhibits133: Eli Lilly and Co. - Overview
Exhibits134: Eli Lilly and Co. - Product / Service
Exhibits135: Eli Lilly and Co. - Key news
Exhibits136: Eli Lilly and Co. - Key offerings
Exhibits137: F. Hoffmann La Roche Ltd. - Overview
Exhibits138: F. Hoffmann La Roche Ltd. - Business segments
Exhibits139: F. Hoffmann La Roche Ltd. - Key news
Exhibits140: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits142: Gilead Sciences Inc. - Overview
Exhibits143: Gilead Sciences Inc. - Product / Service
Exhibits144: Gilead Sciences Inc. - Key news
Exhibits145: Gilead Sciences Inc. - Key offerings
Exhibits146: Medtronic Plc - Overview
Exhibits147: Medtronic Plc - Business segments
Exhibits148: Medtronic Plc - Key news
Exhibits149: Medtronic Plc - Key offerings
Exhibits150: Medtronic Plc - Segment focus
Exhibits151: Novartis AG - Overview
Exhibits152: Novartis AG - Business segments
Exhibits153: Novartis AG - Key offerings
Exhibits154: Novartis AG - Segment focus
Exhibits155: Olympus Corp. - Overview
Exhibits156: Olympus Corp. - Business segments
Exhibits157: Olympus Corp. - Key news
Exhibits158: Olympus Corp. - Key offerings
Exhibits159: Olympus Corp. - Segment focus
Exhibits160: Pfizer Inc. - Overview
Exhibits161: Pfizer Inc. - Product / Service
Exhibits162: Pfizer Inc. - Key news
Exhibits163: Pfizer Inc. - Key offerings
Exhibits164: Sanofi SA - Overview
Exhibits165: Sanofi SA - Business segments
Exhibits166: Sanofi SA - Key news
Exhibits167: Sanofi SA - Key offerings
Exhibits168: Sanofi SA - Segment focus
Exhibits169: Smith and Nephew plc - Overview
Exhibits170: Smith and Nephew plc - Business segments
Exhibits171: Smith and Nephew plc - Key news
Exhibits172: Smith and Nephew plc - Key offerings
Exhibits173: Smith and Nephew plc - Segment focus
Exhibits174: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits175: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits176: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations